Bacil Pharma Limited (BOM:524516)
India · Delayed Price · Currency is INR 20.44
-0.65 (-3.08%)
At close: Oct 22, 2026
Bacil Pharma Market Cap
Bacil Pharma has a market cap or net worth of 293.38 million as of October 22, 2026. It is the 46,552nd most valuable company in the world and the 4,356th biggest in India. Its market cap has decreased by 52.47% in one year.
Market Cap
293.38M
Enterprise Value
338.86M
Revenue
n/a
Global Rank
Country Rank
#4,356 India
PE Ratio
23.84
ChartMarket Cap Chart
Since April 23, 2007, Bacil Pharma's market cap has increased from 21.80M to 293.38M, an increase of 1,245.69%. That is a compound annual growth rate of 14.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 293.38M | -42.65% |
| Dec 31, 2025 | 511.54M | 59.83% |
| Dec 31, 2024 | 320.06M | 751.72% |
| Dec 29, 2023 | 37.58M | -32.13% |
| Dec 23, 2022 | 55.37M | 31.47% |
| Dec 31, 2021 | 42.11M | 51.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Panchsheel Organics | 1.37B |
| Krebs Biochemicals & Industries | 1.23B |
| Himalaya Nutravedics India | 1.18B |
| Tyche Industries | 1.06B |
| Crestchem | 490.95M |
| Vasundhara Rasayans | 432.39M |
| Alfavision Overseas (India) | 357.82M |
| Ishita Drugs and Industries | 232.65M |